Your search returned 4 results.

Results
	1.	Anti-tumour necrosis factor treatment of inflammatory bowel disease in liver transplant recipients. [electronic resource] by Mohabbat, A B Sandborn, W J Loftus, E V Wiesner, R H Bruining, D H Producer: 20130115 In: Alimentary pharmacology & therapeutics vol. 36 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Efficacy and safety of certolizumab pegol for Crohn's disease in clinical practice. [electronic resource] by Moon, W Pestana, L Becker, B Loftus, E V Hanson, K A Bruining, D H Tremaine, W J Kane, S V Producer: 20160108 In: Alimentary pharmacology & therapeutics vol. 42 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	Natalizumab for moderate to severe Crohn's disease in clinical practice: the Mayo Clinic Rochester experience. [electronic resource] by Kane, S V Horst, S Sandborn, W J Becker, B Neis, B Moscandrew, M Hanson, K A Tremaine, W J Bruining, D H Faubion, W A Pardi, D S Harmsen, W S Zinsmeister, A R Loftus, E V Producer: 20130503 In: Inflammatory bowel diseases vol. 18 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	4.	Magnetic resonance enterography is feasible and reliable in multicenter clinical trials in patients with Crohn's disease, and may help select subjects with active inflammation. [electronic resource] by Coimbra, A J F Rimola, J O'Byrne, S Lu, T T Bengtsson, T de Crespigny, A Luca, D Rutgeerts, P Bruining, D H Fidler, J L Sandborn, W J Santillan, C S Higgins, P D R Al-Hawary, M M Vermeire, S Vanbeckevoort, D Vanslembrouck, R Peyrin-Biroulet, L Laurent, V Herrmann, K A Panes, J Producer: 20160706 In: Alimentary pharmacology & therapeutics vol. 43 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)